Opinion

Video

Addressing Concerns About the Financial Impact of Amyloid-Targeting Therapies

Panelists discuss how the substantial financial impact of amyloid-targeting therapies necessitates innovative approaches including value-based pricing models, outcomes-based contracts, risk-sharing arrangements between payers and manufacturers, stratified patient selection criteria, and system-level solutions to balance clinical benefit with economic sustainability for health care systems, insurers, and patients.

Related Videos
1 expert in this video
1 expert in this video
4 experts are featured in this series.
Christine Funke, MD
5 experts are featured in this series
5 experts are featured in this series
Dr Raymond Osarogiagbon
4 experts are featured in this series.
5 experts in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo